Report Detail
Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Report 2021
- RnM3818179 |
- 14 June, 2021 |
- Global |
- 147 Pages |
- QYResearch |
- Pharma & Healthcare
Granulocyte-colony stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream.
Functionally, it is a cytokine and hormone, a type of colony-stimulating factor, and is produced by a number of different tissues. The pharmaceutical analogs of naturally occurring G-CSF are called filgrastim and lenograstim.
G-CSF also stimulates the survival, proliferation, differentiation, and function of neutrophil precursors and mature neutrophils.
Market Analysis and Insights: Global Recombinant Human Granulocyte Colony-Stimulating Market
The global Recombinant Human Granulocyte Colony-Stimulating market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Recombinant Human Granulocyte Colony-Stimulating Scope and Market Size
The global Recombinant Human Granulocyte Colony-Stimulating market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Human Granulocyte Colony-Stimulating market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Lenograstim (Granocyte)
Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
Others
Segment by Application
Chemotherapy Induced Neutropenia
Before Blood Donation
Stem Cell Transplants
Others
The Recombinant Human Granulocyte Colony-Stimulating market is analysed and market size information is provided by regions (countries). Segment by Application, the Recombinant Human Granulocyte Colony-Stimulating market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Amgen
Qilu Pharmaceutical
Shijiazhuang Pharmaceutical
Kyowa Hakko Kirin
Gensci
Amoytop Biotech
Hangzhou Jiuyuan
Huaxin
Triprime
Sinovac
Zhaoke
Kawin
1 Recombinant Human Granulocyte Colony-Stimulating Market Overview
- 1.1 Recombinant Human Granulocyte Colony-Stimulating Product Scope
- 1.2 Recombinant Human Granulocyte Colony-Stimulating Segment by Type
- 1.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016 & 2021 & 2027)
- 1.2.2 Lenograstim (Granocyte)
- 1.2.3 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
- 1.2.4 Others
- 1.3 Recombinant Human Granulocyte Colony-Stimulating Segment by Application
- 1.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Comparison by Application (2016 & 2021 & 2027)
- 1.3.2 Chemotherapy Induced Neutropenia
- 1.3.3 Before Blood Donation
- 1.3.4 Stem Cell Transplants
- 1.3.5 Others
- 1.4 Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Forecasts (2016-2027)
- 1.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size in Value Growth Rate (2016-2027)
- 1.4.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Size in Volume Growth Rate (2016-2027)
- 1.4.3 Global Recombinant Human Granulocyte Colony-Stimulating Price Trends (2016-2027)
2 Recombinant Human Granulocyte Colony-Stimulating Estimates and Forecasts by Region
- 2.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Region: 2016 VS 2021 VS 2027
- 2.2 Global Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario by Region (2016-2021)
- 2.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2016-2021)
- 2.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2016-2021)
- 2.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Forecasts by Region (2022-2027)
- 2.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Estimates and Forecasts by Region (2022-2027)
- 2.3.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Region (2022-2027)
- 2.4 Geographic Market Analysis: Market Facts & Figures
- 2.4.1 North America Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2016-2027)
- 2.4.2 Europe Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2016-2027)
- 2.4.3 China Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2016-2027)
- 2.4.4 Japan Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2016-2027)
- 2.4.5 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2016-2027)
- 2.4.6 India Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2016-2027)
3 Global Recombinant Human Granulocyte Colony-Stimulating Competition Landscape by Players
- 3.1 Global Top Recombinant Human Granulocyte Colony-Stimulating Players by Sales (2016-2021)
- 3.2 Global Top Recombinant Human Granulocyte Colony-Stimulating Players by Revenue (2016-2021)
- 3.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Human Granulocyte Colony-Stimulating as of 2020)
- 3.4 Global Recombinant Human Granulocyte Colony-Stimulating Average Price by Company (2016-2021)
- 3.5 Manufacturers Recombinant Human Granulocyte Colony-Stimulating Manufacturing Sites, Area Served, Product Type
- 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Type
- 4.1 Global Recombinant Human Granulocyte Colony-Stimulating Historic Market Review by Type (2016-2021)
- 4.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2021)
- 4.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2016-2021)
- 4.1.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Type (2016-2021)
- 4.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Forecasts by Type (2022-2027)
- 4.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Type (2022-2027)
- 4.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Type (2022-2027)
- 4.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Price Forecast by Type (2022-2027)
5 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Application
- 5.1 Global Recombinant Human Granulocyte Colony-Stimulating Historic Market Review by Application (2016-2021)
- 5.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2021)
- 5.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application (2016-2021)
- 5.1.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Application (2016-2021)
- 5.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Forecasts by Application (2022-2027)
- 5.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Application (2022-2027)
- 5.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Application (2022-2027)
- 5.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Price Forecast by Application (2022-2027)
6 North America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures
- 6.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Company
- 6.1.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Company (2016-2021)
- 6.1.2 North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021)
- 6.2 North America Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type
- 6.2.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2016-2021)
- 6.2.2 North America Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2022-2027)
- 6.3 North America Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application
- 6.3.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application (2016-2021)
- 6.3.2 North America Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application (2022-2027)
7 Europe Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures
- 7.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Company
- 7.1.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Company (2016-2021)
- 7.1.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021)
- 7.2 Europe Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type
- 7.2.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2016-2021)
- 7.2.2 Europe Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2022-2027)
- 7.3 Europe Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application
- 7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
- 7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)
8 China Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures
- 8.1 China Recombinant Human Granulocyte Colony-Stimulating Sales by Company
- 8.1.1 China Recombinant Human Granulocyte Colony-Stimulating Sales by Company (2016-2021)
- 8.1.2 China Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021)
- 8.2 China Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type
- 8.2.1 China Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2016-2021)
- 8.2.2 China Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2022-2027)
- 8.3 China Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application
- 8.3.1 China 313 Sales Breakdown by Application (2016-2021)
- 8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures
- 9.1 Japan Recombinant Human Granulocyte Colony-Stimulating Sales by Company
- 9.1.1 Japan Recombinant Human Granulocyte Colony-Stimulating Sales by Company (2016-2021)
- 9.1.2 Japan Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021)
- 9.2 Japan Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type
- 9.2.1 Japan Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2016-2021)
- 9.2.2 Japan Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2022-2027)
- 9.3 Japan Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application
- 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
- 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures
- 10.1 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales by Company
- 10.1.1 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales by Company (2016-2021)
- 10.1.2 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021)
- 10.2 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type
- 10.2.1 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2016-2021)
- 10.2.2 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2022-2027)
- 10.3 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application
- 10.3.1 Southeast Asia KG Sales Breakdown by Application (2016-2021)
- 10.3.2 Southeast Asia KG Sales Breakdown by Application (2022-2027)
11 India Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures
- 11.1 India Recombinant Human Granulocyte Colony-Stimulating Sales by Company
- 11.1.1 India Recombinant Human Granulocyte Colony-Stimulating Sales by Company (2016-2021)
- 11.1.2 India Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021)
- 11.2 India Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type
- 11.2.1 India Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2016-2021)
- 11.2.2 India Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2022-2027)
- 11.3 India Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application
- 11.3.1 India Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application (2016-2021)
- 11.3.2 India Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Recombinant Human Granulocyte Colony-Stimulating Business
- 12.1 Amgen
- 12.1.1 Amgen Corporation Information
- 12.1.2 Amgen Business Overview
- 12.1.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
- 12.1.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Products Offered
- 12.1.5 Amgen Recent Development
- 12.2 Qilu Pharmaceutical
- 12.2.1 Qilu Pharmaceutical Corporation Information
- 12.2.2 Qilu Pharmaceutical Business Overview
- 12.2.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
- 12.2.4 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Products Offered
- 12.2.5 Qilu Pharmaceutical Recent Development
- 12.3 Shijiazhuang Pharmaceutical
- 12.3.1 Shijiazhuang Pharmaceutical Corporation Information
- 12.3.2 Shijiazhuang Pharmaceutical Business Overview
- 12.3.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
- 12.3.4 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Products Offered
- 12.3.5 Shijiazhuang Pharmaceutical Recent Development
- 12.4 Kyowa Hakko Kirin
- 12.4.1 Kyowa Hakko Kirin Corporation Information
- 12.4.2 Kyowa Hakko Kirin Business Overview
- 12.4.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
- 12.4.4 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Products Offered
- 12.4.5 Kyowa Hakko Kirin Recent Development
- 12.5 Gensci
- 12.5.1 Gensci Corporation Information
- 12.5.2 Gensci Business Overview
- 12.5.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
- 12.5.4 Gensci Recombinant Human Granulocyte Colony-Stimulating Products Offered
- 12.5.5 Gensci Recent Development
- 12.6 Amoytop Biotech
- 12.6.1 Amoytop Biotech Corporation Information
- 12.6.2 Amoytop Biotech Business Overview
- 12.6.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
- 12.6.4 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Products Offered
- 12.6.5 Amoytop Biotech Recent Development
- 12.7 Hangzhou Jiuyuan
- 12.7.1 Hangzhou Jiuyuan Corporation Information
- 12.7.2 Hangzhou Jiuyuan Business Overview
- 12.7.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
- 12.7.4 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Products Offered
- 12.7.5 Hangzhou Jiuyuan Recent Development
- 12.8 Huaxin
- 12.8.1 Huaxin Corporation Information
- 12.8.2 Huaxin Business Overview
- 12.8.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
- 12.8.4 Huaxin Recombinant Human Granulocyte Colony-Stimulating Products Offered
- 12.8.5 Huaxin Recent Development
- 12.9 Triprime
- 12.9.1 Triprime Corporation Information
- 12.9.2 Triprime Business Overview
- 12.9.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
- 12.9.4 Triprime Recombinant Human Granulocyte Colony-Stimulating Products Offered
- 12.9.5 Triprime Recent Development
- 12.10 Sinovac
- 12.10.1 Sinovac Corporation Information
- 12.10.2 Sinovac Business Overview
- 12.10.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
- 12.10.4 Sinovac Recombinant Human Granulocyte Colony-Stimulating Products Offered
- 12.10.5 Sinovac Recent Development
- 12.11 Zhaoke
- 12.11.1 Zhaoke Corporation Information
- 12.11.2 Zhaoke Business Overview
- 12.11.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
- 12.11.4 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Products Offered
- 12.11.5 Zhaoke Recent Development
- 12.12 Kawin
- 12.12.1 Kawin Corporation Information
- 12.12.2 Kawin Business Overview
- 12.12.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
- 12.12.4 Kawin Recombinant Human Granulocyte Colony-Stimulating Products Offered
- 12.12.5 Kawin Recent Development
13 Recombinant Human Granulocyte Colony-Stimulating Manufacturing Cost Analysis
- 13.1 Recombinant Human Granulocyte Colony-Stimulating Key Raw Materials Analysis
- 13.1.1 Key Raw Materials
- 13.1.2 Key Raw Materials Price Trend
- 13.1.3 Key Suppliers of Raw Materials
- 13.2 Proportion of Manufacturing Cost Structure
- 13.3 Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-Stimulating
- 13.4 Recombinant Human Granulocyte Colony-Stimulating Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
- 14.1 Marketing Channel
- 14.2 Recombinant Human Granulocyte Colony-Stimulating Distributors List
- 14.3 Recombinant Human Granulocyte Colony-Stimulating Customers
15 Market Dynamics
- 15.1 Recombinant Human Granulocyte Colony-Stimulating Market Trends
- 15.2 Recombinant Human Granulocyte Colony-Stimulating Drivers
- 15.3 Recombinant Human Granulocyte Colony-Stimulating Market Challenges
- 15.4 Recombinant Human Granulocyte Colony-Stimulating Market Restraints
16 Research Findings and Conclusion
17 Appendix
- 17.1 Research Methodology
- 17.1.1 Methodology/Research Approach
- 17.1.2 Data Source
- 17.2 Author List
Summary:
Get latest Market Research Reports on Recombinant Human Granulocyte Colony-Stimulating. Industry analysis & Market Report on Recombinant Human Granulocyte Colony-Stimulating is a syndicated market report, published as Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Report 2021. It is complete Research Study and Industry Analysis of Recombinant Human Granulocyte Colony-Stimulating market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
